{"chunk_id": "WHO_GUIDELINES(TRAIN DATA)__chunk_687", "source": "WHO_GUIDELINES(TRAIN DATA)", "text": "ted from the WHO guideline on when to start antiretroviral therapy \nand on pre-exposure prophylaxis for HIV (2015), where it is considered to be a strong recommendation \nbased on high-quality evidence (99). The evidence and further guidance related to the recommendation \ncan be found in this guideline.\n• “Substantial risk” is provisionally defined as HIV incidence greater than 3 per 100 person-years in the \nabsence of PrEP, but individual risk varies within this group depending on individual beh"}